Homelife sciences

life sciences

Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis

Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis

December 18, 2020

Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network

Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network

December 18, 2020

Bet on Rising P/E Investing With These Top 5 Stocks

Bet on Rising P/E Investing With These Top 5 Stocks

December 18, 2020

EyePoint Pharmaceuticals Announces $16.5 Million Monetization of ILUVIEN® Royalty with SWK Holdings Corporation

EyePoint Pharmaceuticals Announces $16.5 Million Monetization of ILUVIEN® Royalty with SWK Holdings Corporation

December 18, 2020

Actinium Pharmaceuticals (ATNM) Stock Sinks As Market Gains: What You Should Know

Actinium Pharmaceuticals (ATNM) Stock Sinks As Market Gains: What You Should Know

December 17, 2020

Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors

Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors

December 17, 2020

CNS Pharmaceuticals Announces Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin

CNS Pharmaceuticals Announces Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin

December 17, 2020

Adial Pharmaceuticals Reaches 35% Enrollment in ONWARD(TM) Pivotal Phase 3 Trial of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals Reaches 35% Enrollment in ONWARD(TM) Pivotal Phase 3 Trial of AD04 for the Treatment of Alcohol Use Disorder

December 17, 2020

Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion

Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion

December 17, 2020

Atossa Therapeutics Announces Pricing of $14.0 Million Registered Direct Offering Priced At-The-Market

Atossa Therapeutics Announces Pricing of $14.0 Million Registered Direct Offering Priced At-The-Market

December 17, 2020

« 1 … 544 545 546 547 548 … 557 »